Gene delivery into hepatocytes with the PreS/liposome/DNA system

Biotechnology Journal

Volumn 3, Issue 9-10, 2008, Pages 1286-1295

  Wang, Zhijun ^a   Yuan, Zhenghong ^b   Jin, Li ^a,b  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Gene therapy; HBV; Transfection; Virus like particle

Indexed keywords

AMINO ACIDS; CELL CULTURE; DNA; EFFICIENCY; GENE TRANSFER; MOLECULAR BIOLOGY; VIRUSES;

CATIONIC LIPOSOMES; HEPATITIS B VIRUS; LIVER-SPECIFIC GENES; TARGET CHARACTERISTIC; TRANSFECTION; TRANSFECTION EFFICIENCY; TRANSFECTION REAGENTS; VIRUS-LIKE PARTICLES;

GENE THERAPY;

BETA GALACTOSIDASE; HISTIDINE; LIPOSOME; NAKED DNA; PLASMID DNA; PRES PROTEIN; PROTEIN; REAGENT; UNCLASSIFIED DRUG; DNA; PRES (120 145) PEPTIDE; PRES (120-145) PEPTIDE; PROTEIN PRECURSOR; VIRUS ENVELOPE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LINE; CONTROLLED STUDY; ENCAPSULATION; EXPRESSION VECTOR; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; MATERIAL COATING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PLASMID; PRIORITY JOURNAL; VIRUS LIKE AGENT; ANIMAL; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; GENETICS; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; WESTERN BLOTTING;

HEPATITIS B VIRUS; MUS;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; DNA; HEPATOCYTES; HUMANS; INJECTIONS, INTRAVENOUS; LIPOSOMES; MICE; MICE, NUDE; PLASMIDS; PROTEIN PRECURSORS; TRANSFECTION; VIRAL ENVELOPE PROTEINS;

EID: 85047683504     PISSN: 15420752     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.200800125     Document Type: Article

References (54)

1. El-Aneed, A., An overview of current delivery systems in cancer gene therapy. J. Control. Release 2004, 94, 1-14.
2. Wang, Y., Yuan, F., Delivery of viral vectors to tumor cells: Extracellular transport, systemic distribution, and strategies for improvement. Ann. Biomed. Eng. 2006, 34, 114-127.
3. Aghi, M., Rabkin, S., Viral vectors as therapeutic agents for glioblastoma. Curr. Opin. Mol. Ther. 2005, 7, 419-430.
4. Rainov, N. G., Kramm, C. M., Vector delivery methods and targeting strategies for gene therapy of brain tumors. Curr. Gene Ther. 2001, 1, 367-383.
5. Picquet, E., Le Ny, K., Delépine, P., Montier, T. et al., Cationic lipophosphoramidates and lipophosphoguanidines are very efficient for in vivo DNA delivery. Bioconjug. Chem. 2005, 16, 1051-1053.
6. Glover, D. J., Lipps, H. J., Jans, D. A., Towards safe, non-viral therapeutic gene expression in humans. Nat. Rev. Genet. 2005, 6, 299-310.
7. Toncheva, V., Wolfert, M. A., Dash, P. R., Oupicky, D. et al., Novel vectors for gene delivery formed by self-assembly of DNA with poly(L-lysine) grafted with hydrophilic polymers. Biochim. Biophys. Acta 1998, 1380, 354-368.
8. Goula, D., Benoist, C., Mantero, S., Merlo, G. et al., Polyethylenimine-based intravenous delivery of transgenes to mouse lung. Gene Ther. 1998, 5, 1291-1295.
9. Guy, J., Drabek, D., Antoniou M., Delivery of DNA into mammalian cells by receptor-mediated endocytosis and gene therapy. Mol. Biotechnol. 1995, 3, 237-248.
10. Martin, B., Sainlos, M., Aissaoui, A., Oudrhiri, N. et al., The design of cationic lipids for gene delivery. Curr. Pharm. Des. 2005, 11, 375-394.
11. Labat-Moleur, F., Steffan, A. M., Brisson, C., Perron, H. et al., An electron microscopy study into the mechanism of gene transfer with lipopolyamines. Gene Ther. 1996, 3, 1010-1017.
12. Verma, I. M., Somia, N., Gene therapy - Promises, problems and prospects. Nature 1997, 389, 239-242.
13. Arlen, P. A., Singleton, M., Adamovicz, J. J., Ding, Y. et al., Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts. Infect. Immun. 2008, 76, 3640-3650.
14. Griesenbach, U., Geddes, D. M., Alton, E. W., Gene therapy progress and prospects: Cystic fibrosis. Gene Ther. 2006, 13, 1061-1067.
15. Ledley, F. D., Pharmaceutical approach to somatic gene therapy. Pharm. Res. 1996, 13, 1595-1614.
16. Petry, H., Goldmann, C., Ast, O., Luke, W., The use of virus-like particles for gene transfer. Curr. Opin. Mol. Ther. 2003, 5, 524-528.
17. Garcea, R. L., Gissmann, L., Virus-like particles as vaccines and vessels for the delivery of small molecules. Curr. Opin. Biotechnol. 2004, 15, 513-517.
18. Palucha, A., Loniewska, A., Satheshkumar, S., Boguszewska-Chachulska, A. M. et al., Virus-like particles: Models for assembly studies and foreign epitope carriers. Prog. Nucleic Acid Res. Mol. Biol. 2005, 80, 135-168.
19. Gilbert, S. C., Virus-like particles as vaccine adjuvants. Mol. Biotechnol. 2001, 19, 169-177.
20. Aoyama, Y., Kanamori, T., Nakai, T., Sasaki T,. et al., Artificial viruses and their application to gene delivery. Size-controlled gene coating with glycocluster nanoparticles. J. Am. Chem. Soc. 2003, 125, 3455-3457.
21. Limaye, A., Koya, V., Samsam, M., Daniell, H., Receptor-mediated oral delivery of a bioencapsulated green fluorescent protein expressed in transgenic chloroplasts into the mouse circulatory system. FASEB J. 2006, 20, 959-961.
22. Huang, Y., Liang, W., Wang, Y., Zhou, Z. et al., Immunogenicity of the epitope of the foot-and-mouth disease virus fused with a hepatitis B core protein as expressed in transgenic tobacco. Viral Immunol. 2005, 18, 668-677.
23. De Meyer, S., Gong, Z. J., Suwandhi, W., van Pelt, J. et al., Organ and species specificity of hepatitis B virus (HBV) infection: A review of literature with a special reference to preferential attachment of HBV to human hepatocytes. J. Viral Hepat. 1997, 4, 145-153.
24. Le Seyec, J., Chouteau, P., Cannie, I., Guguen-Guillouzo, C., Gripon, P., Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain. J. Virol. 1999, 73, 2052-2057.
25. Argnani, R., Boccafogli, L., Marconi, P. C., Manservigi, R., Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide. Gene Ther. 2004, 11, 1087-1098.
26. Przewlocki, G., Audibert, F., Jolivet, M., Chedid, L. et al., Production of antibodies recognizing a hepatitis B virus (HBV) surface antigen by administration of murabutide associated to a synthetic pre-S HBV peptide conjugated to a toxoid carrier. Biochem. Biophys. Res. Commun. 1986, 140, 557-564.
27. Neurath, A. R., Kent, S. B., Strick, N., Parker, K., Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 1986, 46, 429-436.
28. Gregoriadis, G., McCormack, B., Obrenovic, M., Saffie, R. et al., Vaccine entrapment in liposomes. Methods 1999, 19, 156-162.
29. Perrie, Y., Gregoriadis, G., Liposome-entrapped plasmid DNA: Characterisation studies. Biochim. Biophys. Acta 2000, 1475, 125-132.
30. Noites, I. S., O'Kennedy, R. D., Levy, M. S., Abidi, N., Keshavarz-Moore, E., Rapid quantitation and monitoring of plasmid DNA using an ultrasensitive DNA-binding dye. Biotechnol. Bioeng. 1999, 66, 195-201.
31. Mosmann, T., Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63.
32. Young, L. S., Searle, P. F., Onion, D., Mautner, V., Viral gene therapy strategies: From basic science to clinical application. J. Pathol. 2006, 208, 299-318.
33. Zhang, X., Yu, C., Zhang, C., Tang, T., Dai, K., Direct chitosan-mediated gene delivery to the rabbit knee joints in vitro and in vivo. Biochem. Biophys. Res. Commun. 2006, 341, 202-208.
34. Zhang, X., Ercelen, S., Duportail, G., Schaub, E. et al., Hydrophobically modified low molecular weight chitosans as efficient and nontoxic gene delivery vectors. J. Gene Med. 2008, 10, 527-539.
35. Mével, M., Breuzard, G., Yaouanc, J. J., Clément, J. C. et al., Synthesis and transfection activity of new cationic phosphoramidate lipids: High efficiency of an imidazolium derivative. Chembiochem. 2008, 9, 1462-1471.
36. Aoki, M., Ishii, T., Kanaoka, M., Kimura, T., RNA interference in immune cells by use of osmotic delivery of siRNA. Biochem. Biophys. Res. Commun. 2006, 341, 326-333.
37. Morishita, N., Nakagami, H., Morishita, R., Takeda, S. et al., Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector. Biochem. Biophys. Res. Commun. 2005, 334, 1121-1126.
38. Hattori, Y., Kawakami, S., Suzuki, S., Yamashita, F., Hashida, M., Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice. Biochem. Biophys. Res. Commun. 2004, 317, 992-999.
39. Honma, K., Ochiya, T., Nagahara, S., Sano, A. et al., Atelocollagen-based gene transfer in cells allows high-throughput screening of gene functions. Biochem. Biophys. Res. Commun. 2001, 289, 1075-1081.
40. Tang, F., Hughes, J. A., Introduction of a disulfide bond into a cationic lipid enhances transgene expression of plasmid DNA. Biochem. Biophys. Res. Commun. 1998, 242, 141-145.
41. Holmberg, E. G., Reuer, Q. R., Geisert, E. E., Owens, J. L., Delivery of plasmid DNA to glial cells using pH-sensitive immunoliposomes. Biochem. Biophys. Res. Commun. 1994, 201, 888-893.
42. Condiotti, R., Curran, M. A., Nolan, G. P., Giladi, H. et al., Prolonged liver-specific transgene expression by a non-primate lentiviral vector. Biochem. Biophys. Res. Commun. 2004, 320, 998-1006.
43. Yoshida, S., Kashiwamura, S. I., Hosoya, Y., Luo, E. et al., Direct immunization of malaria DNA vaccine into the liver by gene gun protects against lethal challenge of Plasmodium berghei sporozoite. Biochem. Biophys. Res. Commun. 2000, 271, 107-115.
44. Sasaki, H., Yoshida, S., Kitahara, T., Yoshioka, T. et al., Influence of disease stage on polyethylenimine-mediated plasmid DNA delivery in murine hepatitis. Int. J. Pharm. 2006, 318, 139-145.
45. Schatzlein, A. G., Zinselmeyer, B. H., Elouzi, A., Dufes, C. et al., Preferential liver gene expression with polypropylenimine dendrimers. J. Control. Release 2005, 101, 247-258.
46. Jiang, X., Dai, H., Leong, K. W., Goh, S. H. et al., Chitosan-g-PEG/DNA complexes deliver gene to the rat liver via intrabiliary and intraportal infusions. J. Gene Med. 2006, 8, 477-487.
47. Urban, S., Breiner, K. M., Fehler, F., Klingmuller, U., Schaller, H., Avian hepatitis B virus infection is initiated by the interaction of a distinct pre-S subdomain with the cellular receptor gp 180. J. Virol. 1998, 72, 8089-8097.
48. Leenders, W. P., Glansbeek, H. L., de Bruin, W. C., Yap, S. H., Binding of the major and large HBsAg to human hepatocytes and liver plasma membranes: Putative external and internal receptors for infection and secretion of hepatitis B virus. Hepatology 1990, 12, 141-147.
49. Budkowska, A., Quan, C., Groh, F., Bedossa, P. et al., Hepatitis B virus (HBV) binding factor in human serum: Candidate for a soluble form of hepatocyte HBV receptor. J. Virol. 1993, 67, 4316-4322.
50. Bchini, R., Capel, F., Dauguet, C., Dubanchet, S., Petit, M. A., In vitro infection of human hepatoma (HepG2) cells with hepatitis B virus. J. Virol. 1990, 64, 3025-3032.
51. de Bruin, W. C., Hertogs, K., Leenders, W. P., Depla, E., Yap, S. H., Hepatitis B virus: Specific binding and internalization of small HBsAg by human hepatocytes. J. Gen. Virol. 1995, 76, 1047-1050.
52. Paran, N., Geiger, B., Shaul, Y., HBV infection of cell culture: Evidence for multivalent and cooperative attachment. EMBO J. 2001, 20, 4443-4453.
53. Gripon, P, Cannie, I, Urban, S., Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein. J. Virol. 2005, 79, 1613-1622.
54. Petersen, J., Dandri, M., Mier, W., Lütgehetmann, M. et al. Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. Nat. Biotechnol. 2008, 26, 335-341.